216 related articles for article (PubMed ID: 20298986)
1. Patent foramen ovale closure for migraine prevention: the subject is still open.
Dodick DW
JACC Cardiovasc Interv; 2010 Mar; 3(3):288-9. PubMed ID: 20298986
[No Abstract] [Full Text] [Related]
2. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism.
Rigatelli G; Dell'Avvocata F; Ronco F; Cardaioli P; Giordan M; Braggion G; Aggio S; Chinaglia M; Rigatelli G; Chen JP
JACC Cardiovasc Interv; 2010 Mar; 3(3):282-7. PubMed ID: 20298985
[TBL] [Abstract][Full Text] [Related]
3. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
4. Migraine and percutaneous patent foramen ovale closure: a systematic review and meta-analysis.
Shi YJ; Lv J; Han XT; Luo GG
BMC Cardiovasc Disord; 2017 Jul; 17(1):203. PubMed ID: 28747203
[TBL] [Abstract][Full Text] [Related]
5. Patent Foramen Ovale Closure for Stroke Prevention and Other Disorders.
Collado FMS; Poulin MF; Murphy JJ; Jneid H; Kavinsky CJ
J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29910192
[No Abstract] [Full Text] [Related]
6. Transcatheter patent foramen ovale closure is effective in reducing migraine independently from specific interatrial septum anatomy and closure devices design.
Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Braggion G; Chinaglia M; Roncon L
Cardiovasc Revasc Med; 2010; 11(1):29-33. PubMed ID: 20129358
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous closure of patent foramen ovale for migraine headaches refractory to medical treatment.
Wahl A; Praz F; Findling O; Nedeltchev K; Schwerzmann M; Tai T; Windecker S; Mattle HP; Meier B
Catheter Cardiovasc Interv; 2009 Jul; 74(1):124-9. PubMed ID: 19180663
[TBL] [Abstract][Full Text] [Related]
8. Improvement of migraine headaches after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism.
Wahl A; Praz F; Tai T; Findling O; Walpoth N; Nedeltchev K; Schwerzmann M; Windecker S; Mattle HP; Meier B
Heart; 2010 Jun; 96(12):967-73. PubMed ID: 20538672
[TBL] [Abstract][Full Text] [Related]
9. The conundrum of migraine headaches in the presence of patent foramen ovale.
Tobis J
Catheter Cardiovasc Interv; 2009 Jul; 74(1):130-1. PubMed ID: 19530214
[No Abstract] [Full Text] [Related]
10. Thrombus in a Hypercoagulable Patient Following Patent Foramen Ovale Closure With the Gore Septal Occluder.
Luc JGY; Bakar SN; Kiaii B; Sridhar K
JACC Cardiovasc Interv; 2018 Jun; 11(11):1108-1109. PubMed ID: 29778728
[No Abstract] [Full Text] [Related]
11. Patent foramen ovale and migraine headaches: the saga continues.
Tobis J
Catheter Cardiovasc Interv; 2011 Mar; 77(4):575-6. PubMed ID: 21351232
[No Abstract] [Full Text] [Related]
12. Double standards in the world of ASD and PFO management: closure for paradoxical embolism.
Carroll JD
Catheter Cardiovasc Interv; 2009 Dec; 74(7):1070-1. PubMed ID: 19950331
[No Abstract] [Full Text] [Related]
13. Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.
Luna M; Banerjee S; Brilakis ES
Cardiovasc Revasc Med; 2010; 11(1):63-6. PubMed ID: 20129363
[TBL] [Abstract][Full Text] [Related]
14. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
Spies C; Timmermanns I; Reissmann U; van Essen J; Schräder R
Catheter Cardiovasc Interv; 2008 Feb; 71(3):390-5. PubMed ID: 18288745
[TBL] [Abstract][Full Text] [Related]
15. Asymptomatic significant patent foramen ovale: giving patent foramen ovale management back to the cardiologist.
Rigatelli G; Cardaioli P; Chinaglia M
Catheter Cardiovasc Interv; 2008 Mar; 71(4):573-7. PubMed ID: 18307240
[TBL] [Abstract][Full Text] [Related]
16. Pacemaker lead entrapment complicating transcatheter closure of a patent foramen ovale.
Quevedo HC; Arain SA; Abi Rafeh N
JACC Cardiovasc Interv; 2014 Nov; 7(11):e171-2. PubMed ID: 25459047
[No Abstract] [Full Text] [Related]
17. Transcatheter Patent Foramen Ovale Closure After Cryptogenic Stroke: An Updated Meta-Analysis of Randomized Trials.
Mojadidi MK; Elgendy AY; Elgendy IY; Mahmoud AN; Elbadawi A; Eshtehardi P; Patel NK; Wayangankar S; Tobis JM; Meier B
JACC Cardiovasc Interv; 2017 Nov; 10(21):2228-2230. PubMed ID: 29122137
[No Abstract] [Full Text] [Related]
18. [Interventional closure of persistent foramen ovale in patients after crytogenic stroke].
Chatterjee T; Akin I; Nienaber CA; Rehders TC; Ortak J; Chatterjee A; Ince H
Praxis (Bern 1994); 2010 Oct; 99(20):1203-15. PubMed ID: 20931496
[TBL] [Abstract][Full Text] [Related]
19. Predictors of recurrent stroke after percutaneous closure of patent foramen ovale.
Rudolph V; Augustin J; Hofmann T; Hamm CW; Meinertz T; Köster R; Baldus S; Franzen O
EuroIntervention; 2014; 9(12):1418-22. PubMed ID: 24169021
[TBL] [Abstract][Full Text] [Related]
20. The effect of patent foramen ovale closure on visual aura without headache or typical aura with migraine headache.
Khessali H; Mojadidi MK; Gevorgyan R; Levinson R; Tobis J
JACC Cardiovasc Interv; 2012 Jun; 5(6):682-7. PubMed ID: 22721665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
